Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 5, 1996, Pages 793-800

  Allen, Samuel M ^a   Rice, Steven N ^a  

^a North Mississippi Regional Center   (United States)

Author keywords

Atypical neuroleptics; Lesch Nyhan syndrome; Risperidone; Self mutilation

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; ALLOPURINOL; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPHENAZINE; FOLIC ACID; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NEUROLEPTIC AGENT; OXIDOPAMINE; RISPERIDONE; SEROTONIN; THIORIDAZINE;

ADULT; ARTICLE; AUTOMUTILATION; CASE REPORT; DRUG EFFICACY; HUMAN; LESCH NYHAN SYNDROME; MALE; NEOSTRIATUM; RECEPTOR AFFINITY;

EID: 0030197645     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(96)00059-0     Document Type: Article

References (22)

1. BREESE, G. R., McCOWN, T. J., BAUMEISTER, A. A., EMERICK, S. G., FRYE, G. D., and MUELLER, R. A. (1984a) L-DOPA Induced Self-Biting in Rats Treated with 6-Hydroxydopamine (6-OHDA) as Neonates: Models of Self-Mutilation Observed in the Lesch-Nyhan Syndrome. Fed. Proc. 43: 928.
2. BREESE, G. R., BAUMEISTER, A. A., McCOWN, T. J., EMERICK, S. G., FRYE, G. D., CROTTY, K., MUELLER, R. A. (1984b) Behavioral Differences Between Neonatal and Adult 6-Hydroxydopamine-Treated Rats to Dopamine Agonists: Relevance to Neurological Symptoms in Clinical Syndromes with Reduced Brain Dopamine. J. Pharmacol. Exp. Ther. 231: 343-354
3. BREESE G. R., CRISWELL, H. E. and MUELLER, R. A. (1990) Evidence that Lack of Brain Dopamine during Development can Increase the Susceptibility for Aggression and Self-Injurious Behavior by Influencing D1-Dopamine Receptor Function. Prog. Neuro Psychopharmacol. Biol. Psychiat. 14: 565-580.
4. CRISWELL, H. E., MUELLER, R. A. and BREESE, G. A. (1989) Clozapine Antagonism of D-1 and D-2 Dopamine Receptor-Mediated Behaviors. Eur. J. of Pharmacol. 159: 141-147.
5. GERLACH, J. (1991) New Antipsychotics: Classification, Efficacy, and Adverse Effects. Schizophr. Bull. 17: 289-309.
6. JANKOVIC, J., CASKEY, T. C., STOUT, J. T. and BUTLER I. J. (1988) Lesch-Nyhan Syndrome: A Study of Motor Behavior and Cerebrospinal Fluid Neurotransmitters. Ann. Neurol. 23: 466-469.
7. KELLEY, W. N. and WYNGAARDEN J. B. (1978) The Lesch-Nyhan Syndrome. In: The Metabolic Basis of Inherited Disease, 4th ed., J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson (Eds.), pp 1011-36, McGraw-Hill, New York.
8. LEHNINGER, A. L., NELSON, D. L., and COX, M. M. (1993) Principles of Biochemistry, 3rd ed., Worth Publishers, New York, pp 729.
9. LESCH, M. and NYHAN, W. L. (1964) A Familial Disorder of Uric Acid Metabolism and Central Nervous System Function. Am. J. Med. 36: 561-570.
10. LLOYD, K. G., HORNYKIEWICZ, O., DAVIDSON, L., SHANNAK, K., FARLEY, I., GOLDSTEIN, M., SHIBUYA, M., KELLEY, W. N. and FOX, I. H. (1981) Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch Nyhan Syndrome. N. Eng. J. Med. 305: 1106 1111.
11. LUTHMAN, J., BOLIOLI, B., TSUTSUMI, T., VERHOFSTAD, A. and JONSSON, G. (1987) Sprouting of Striatal Serotonin Nerve Terminals Following Selective Lesions of the Nigro Striatal Dopamine Neurons in Neonatal Rats. Brain Res. Bull. 19: 269-274.
12. MIZUNO, T. and YUGARI, Y. (1975) Prophylactic Effect of L-5 Hydroxytryptophan on Self-Mutilation in the Lesch-Nyhan Syndrome. Neuropaediatrie 6: 13-23.
13. NYHAN, W. L. (1976) Behavior in the Lesch-Nyhan Syndrome. J. Autism Chid. Schiz. 6: 235-252.
14. PLECH, A., BRUS, R., KALBFLEISCH, J. H. and KOSTRZEWA, R. M. (1995) Enhanced Oral Activity Responses to Intrastriatal SKF 38393 and m-CPP are Attenuated by Intrastriatal Mianserin in Neonatal 6 OHDA-Lesioned Rats. Psychopharmacology 119: 466-473.
15. ROSENGARTEN, H., SCHWEITZER, J. W. and FRIEDHOFF, A. J. (1983) Induction of Oral Dyskinesias in Naive Rats by D1 Stimulation. Life Sci. 33: 2479-2482.
16. ROTH, B. L., CRAIGO, S. C., CHOUDHARY, M. S., ULUER, A., MONSMA, F. J., SHEN, Y., MELTZER, H. Y. and SIBLEY, D. R. (1994) Binding of Typical and Atypical Agents to 5 Hydroxytryptamine 6 and 5 Hydroxytryptamine 7 Receptors. J. Pharmacol. Exp. Ther. 268: 1403-1410.
17. SCULLEY, D. G., DAWSON, P. A., EMMERSON, B. T. and GORDON, R. B. (1992) A Review of the Molecular Basis of Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Deficiency. Hum. Genet. 90: 195-207.
18. SEEGMILLER, J. E., ROSENBLOOM, F. M. and KELLEY, W. N. (1967) Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis. Science 155: 1682-1685.
19. SILVERSTEIN, F. S., JOHNSON, M. V., HUTCHINSON, R. J. and EDWARDS, N. L. (1985) Lesch-Nyhan Syndrome: CSF Neurotransmitter Abnormalities. Neurology 35: 907-911.
20. SUMIYOSHI, T., KIDO, H., SAKAMOTO, H., URASAKI, K., SUZUKI, K., YAMAGUCHI, N., MORI, H., SHIBA, K. and YOKOGAWA, K. (1994) In Vivo Dopamine-D2 and Serotonin-5-HT2 Receptor Binding Study of Risperidone and Haloperidol. Pharmacol. Biochem. Behav. 47: 553-557.
21. TOWLE, A. C., CRISWELL, H. E., MAYNARD, E. H., LAUDER, J. M., JOH, T. H., MUELLER, R. A. and BREESE, G. R. (1989) Serotonergic Innervation of the Rat Caudate Following a Neonatal 6 Hydroxydopamine Lesion: An Anatomical, Biochemical, and Pharmacological Study. Pharmacol. Biochem. Behav. 34: 367-374.
22. WATTS, R. W. E., SPELLACY, E., GIBBS, D. A., ALLSOP, J., McKERAN, R. O. and SLAVIN, G. E. (1982) Clinical, Post-Mortem, Biochemical and Therapeutic Observations on the Lesch-Nyhan Syndrome with Particular Reference to the Neurological Manifestations. Q. J. Med. 201: 43-78.